Effects of an Optimized Aged Garlic Extract on Cardiovascular Disease Risk Factors in Moderate Hypercholesterolemic Subjects: A Randomized, Crossover, Double-Blind, Sustainedand Controlled Study.

S-allyl-L-cysteine aged garlic extract blood pressure cardiovascular disease risk factor hypercholesterolemia pulse pressure

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
18 Jan 2022
Historique:
received: 29 11 2021
revised: 22 12 2021
accepted: 26 12 2021
entrez: 12 3 2022
pubmed: 13 3 2022
medline: 16 3 2022
Statut: epublish

Résumé

The consumption of aged black garlic (ABG) has been related to improvements in several cardiovascular disease (CVD) risk factors. However, the extent of the beneficial effects depends on the garlic aging process and the amount and type of chemical compounds accumulated. The main objective of this study was to assess the effect of daily intake of a well-characterized ABG extract with a standardized S-allyl-L-cysteine (SAC) yield in combination with dietary recommendations regarding CVD risk factors in individuals with moderate hypercholesterolemia. Sixty-seven hypercholesterolemic individuals with low-density lipoprotein cholesterol levels ≥115 mg/dL were randomized in a crossover, double-blind, sustained, and controlled intervention study. The participants consumed 250 mg (1.25 mg SAC)/tablet/day ABG or a placebo for 6 weeks, with 3 weeks of washout. Blood and pulse pressure and other CVD risk biomarkers were determined at the beginning and end of each intervention. At 6 weeks, ABG extract reduced diastolic blood pressure (DBP) (mean (95% CI) −5.85 (−10.5; −1.3) mm Hg) compared to the placebo, particularly in men with a DBP > 75 mm Hg. The consumption of an improved ABG extract with 1.25 mg of SAC decreased DBP, particularly in men with moderate hypercholesterolemia. The potential beneficial effects of ABG may contribute to obtaining an optimal DBP.

Identifiants

pubmed: 35276764
pii: nu14030405
doi: 10.3390/nu14030405
pmc: PMC8838962
pii:
doi:

Substances chimiques

Plant Extracts 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Centre for the Development of Industrial Technology (CDTI) of the Spanish Ministry of Science and Innovation, grant number.
ID : EXP 00109491/IDI-20180389

Références

Prev Nutr Food Sci. 2016 Dec;21(4):398-405
pubmed: 28078266
Nutrients. 2018 Jun 24;10(7):
pubmed: 29937536
J Exp Bot. 2004 Aug;55(404):1903-18
pubmed: 15234988
J Hypertens. 2020 Jun;38(6):982-1004
pubmed: 32371787
Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1253-61
pubmed: 25149893
J Food Sci. 2016 Jul;81(7):C1662-8
pubmed: 27300762
Am J Clin Nutr. 2020 Dec 10;112(6):1584-1598
pubmed: 33022695
Exp Ther Med. 2020 Feb;19(2):1585-1593
pubmed: 32010343
Biotechnol Prog. 2004 Jan-Feb;20(1):32-7
pubmed: 14763820
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Nutrition. 2014 Sep;30(9):1034-9
pubmed: 24976429
Phytother Res. 2019 Sep;33(9):2179-2191
pubmed: 31294508
Molecules. 2014 Oct 20;19(10):16811-23
pubmed: 25335109
Clin Cardiol. 2015 Sep;38(9):527-34
pubmed: 26418518
Nutr Res. 2014 Feb;34(2):106-15
pubmed: 24461311
J Agric Food Chem. 2020 Nov 25;68(47):14049-14058
pubmed: 33166446
Integr Blood Press Control. 2016 Jan 27;9:9-21
pubmed: 26869811
Food Chem. 2016 Nov 15;211:41-50
pubmed: 27283605
Ann Intern Med. 2015 Nov 17;163(10):778-86
pubmed: 26458123
Am J Clin Nutr. 2003 Sep;78(3):370-5
pubmed: 12936917
Mediators Inflamm. 2013;2013:285795
pubmed: 23533302
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Exp Ther Med. 2020 Feb;19(2):1472-1478
pubmed: 32010325
Am J Cardiovasc Drugs. 2015 Dec;15(6):403-14
pubmed: 26062915
Foods. 2019 Jul 05;8(7):
pubmed: 31284512
Arch Med Sci Atheroscler Dis. 2019 Apr 09;4:e32-e37
pubmed: 31211268
Eur J Clin Nutr. 2013 Jan;67(1):64-70
pubmed: 23169470
J Agric Food Chem. 2015 Jan 21;63(2):683-91
pubmed: 25549134
Nutrients. 2019 Jan 12;11(1):
pubmed: 30642033
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
BMJ. 2020 Apr 1;369:m696
pubmed: 32238384
Integr Blood Press Control. 2014 Dec 09;7:71-82
pubmed: 25525386
Maturitas. 2010 Oct;67(2):144-50
pubmed: 20594781
J Food Drug Anal. 2017 Jan;25(1):62-70
pubmed: 28911544
Molecules. 2017 Jun 01;22(6):
pubmed: 28587168
Front Nutr. 2018 Dec 11;5:122
pubmed: 30619868
Exp Ther Med. 2020 Feb;19(2):1574-1584
pubmed: 32010342

Auteurs

Rosa M Valls (RM)

Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.

Judit Companys (J)

Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.

Lorena Calderón-Pérez (L)

Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.

Patricia Salamanca (P)

Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.

Laura Pla-Pagà (L)

Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.

Berner Andrée Sandoval-Ramírez (BA)

Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.

Antonio Bueno (A)

Lipid Unit, Clinical Analysis and Biochemistry Service, Hospital San Jorge de Huesca, 22004 Huesca, Spain.

Jose Puzo (J)

Lipid Unit, Clinical Analysis and Biochemistry Service, Hospital San Jorge de Huesca, 22004 Huesca, Spain.

Anna Crescenti (A)

Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.

Josep M Del Bas (JMD)

Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.

Antoni Caimari (A)

Eurecat, Centre Tecnològic de Catalunya, Biotechnology Area, Av/de la Universitat, 1, 43204 Reus, Spain.

Aurora Salamanca (A)

Pharmactive Biotech Products, S.L., C/Faraday 7, 28049 Madrid, Spain.

Alberto E Espinel (AE)

Pharmactive Biotech Products, S.L., C/Faraday 7, 28049 Madrid, Spain.

Anna Pedret (A)

Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.

Lluís Arola (L)

Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, Av/de la Universitat, 1, 43204 Reus, Spain.
Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Campus Sescelades, Universitat Rovira i Virgili, 43007 Tarragona, Spain.

Rosa Solà (R)

Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç, 21, 43201 Reus, Spain.
Internal Medicine Service, Hospital Universitari Sant Joan de Reus, Av/del Doctor Josep Laporte, 2, 43204 Reus, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH